menu search

ROQAF / Roquefort files to patent anti-cancer therapeutics globally

Roquefort files to patent anti-cancer therapeutics globally
Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) has announced the successful filing of a global patent for its anti-cancer therapeutics. Once approved, the international phase PCT (patent treaty cooperation) patent would cover the invention of Roquefort's RNA oligonucleotide and mRNA therapeutics in over 155 countries, the company said in a statement. Read More
Posted: Aug 14 2023, 03:56
Author Name: Proactive Investors
Views: 062558

ROQAF News  

Roquefort Therapeutics preparing targets for clinic as eyes commercial deals

By Proactive Investors
September 27, 2023

Roquefort Therapeutics preparing targets for clinic as eyes commercial deals

Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) is "on course with targets for clinical readiness" for one of its development programmes in the seco more_horizontal

Roquefort files to patent anti-cancer therapeutics globally

By Proactive Investors
August 14, 2023

Roquefort files to patent anti-cancer therapeutics globally

Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) has announced the successful filing of a global patent for its anti-cancer therapeutics. Once approv more_horizontal

Roquefort Therapeutics takes big stride in the development of new style of cancer treatment

By Proactive Investors
August 7, 2023

Roquefort Therapeutics takes big stride in the development of new style of cancer treatment

Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) has announced the successful development of new small interfering RNA (siRNA) sequences - a signifi more_horizontal


Search within

Pages Search Results: